Literature DB >> 29548564

Managing health expenditure inflation under a single-payer system: Taiwan's National Health Insurance.

Winnie C Yip1, Yue-Chune Lee2, Shu-Ling Tsai3, Bradley Chen4.   

Abstract

As nations strive to achieve and sustain universal health coverage (UHC), they seek answers as to what health system structures are more effective in managing health expenditure inflation. A fundamental macro-level choice a nation has to make is whether to adopt a single- or a multiple-payer health system. Using Taiwan's National Health Insurance (NHI) as a case, this paper examines how a single-payer system manages its health expenditure growth and draws lessons for other countries whose socioeconomic development is similar to Taiwan's. Our analyses show that as a single payer, Taiwan's NHI is able to exercise its monopsony power to manage its health expenditure growth. This is achieved primarily through the adoption of a system-wide global budget. The global budget sets a hard aggregate budget cap to limit NHI's total spending to its expected revenue, with the annual budget growth rate established by a process of negotiation among key stakeholders. The global budget system is complemented by comprehensive and continuous monitoring and review of encounter records of all providers and patients, enabled by the NHI's advanced information technology. However, by paying its providers using a point-based fee schedule, Taiwan's NHI suffers from inefficient service provision. In particular, providers have incentives to increase use of services and drugs with positive profit margins. Furthermore, Taiwan demonstrates that its control of NHI expenditure growth might be leading it to inadequately meet the changing needs of the population, resulting in the rapid growth of private insurance to cover services excluded or not fully covered by the NHI. If this trend persists and results in a two-tier system, Taiwan's NHI may risk compromising the equity it has achieved in the past two decades.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Efficiency; Financial sustainability; Global budget; Health expenditure control; National health insurance; Single payer; Taiwan; Universal health coverage

Year:  2017        PMID: 29548564     DOI: 10.1016/j.socscimed.2017.11.020

Source DB:  PubMed          Journal:  Soc Sci Med        ISSN: 0277-9536            Impact factor:   4.634


  6 in total

1.  Why people select the outpatient clinic of medical centers: a nationwide analysis in Taiwan.

Authors:  Ming-Hwai Lin; Hsiao-Ting Chang; Tzeng-Ji Chen; Shinn-Jang Hwang
Journal:  PeerJ       Date:  2020-08-27       Impact factor: 2.984

2.  Do informed consumers in Taiwan favour larger hospitals? A 10-year population-based study on differences in the selection of healthcare providers among medical professionals, their relatives and the general population.

Authors:  Raymond N Kuo; Wanchi Chen; Yuting Lin
Journal:  BMJ Open       Date:  2019-05-16       Impact factor: 2.692

3.  Artificial Neural Network and Cox Regression Models for Predicting Mortality after Hip Fracture Surgery: A Population-Based Comparison.

Authors:  Cheng-Yen Chen; Yu-Fu Chen; Hong-Yaw Chen; Chen-Tsung Hung; Hon-Yi Shi
Journal:  Medicina (Kaunas)       Date:  2020-05-19       Impact factor: 2.430

4.  Setting up a three-stage pre-endoscopy triage during the coronavirus disease 2019 pandemic: A multicenter observational study.

Authors:  Tao-Chieh Liu; Chen-Ling Peng; Fang-Yu Hsu; Li-Chun Chang; Hsiu-Po Wang; Wei-Kuo Chang
Journal:  DEN open       Date:  2022-08-08

5.  The correlation between economic fluctuation, workforce employment and health expenditure in the BRICS countries.

Authors:  Lingyan Gu; Mei-Chih Wang; Fangjhy Li
Journal:  Front Public Health       Date:  2022-09-09

6.  Utilization and expenses of outpatient services among tuberculosis patients in three Chinese counties: an observational comparison study.

Authors:  Xuan-Xuan Wang; Jia-Ying Chen; Hui Jiang; An-Na Zhu; Qian Long; John S Ji
Journal:  Infect Dis Poverty       Date:  2019-10-04       Impact factor: 4.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.